Anti-tumor properties of lymphocytes activated by the oxidizing mitogens

J. Wang, Manikkam Suthanthiran, A. Walle, M. Lagman, R. Schwartz, V. Murthi, A. Novogrodsky, K. H. Stenzel

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Human peripheral blood mononuclear cells when activated with the oxidizing mitogens, neuraminidase/galactose oxidase or sodium periodate, express cytolytic activity for freshly isolated tumor cells and for a variety of cell lines, including NK-resistant solid tumor lines. Normal lymphoid cells are not targets for cytotoxicity and do not inhibit lysis of susceptible targets mediated by the oxidizing mitogen-activated mononuclear cells. The cytotoxic response is rapidly generated and reaches peak levels at 48 hr. The oxidizing mitogens induce expression of IL 2 receptors on peripheral blood mononuclear cells. Combined treatment of cells with IL 2 and the oxidizing mitogens results in a marked enhancement of cytotoxicity. Enhancement is achieved at levels of IL 2 that alone result in minimal generation of cytotoxic cells. Growth of a human renal cancer cell line in nude mice was inhibited when the renal cancer cells were injected together with oxidizing mitogen-activated human mononuclear cells. These studies indicate that oxidizing mitogen-activated cells provide a potentially valuable source of material for the adoptive immunotherapy of tumors.

Original languageEnglish
Pages (from-to)4735-4739
Number of pages5
JournalJournal of Immunology
Volume136
Issue number12
Publication statusPublished - 27 Aug 1986
Externally publishedYes

Fingerprint

Mitogens
Lymphocytes
Neoplasms
Interleukin-2
Blood Cells
Galactose Oxidase
Adoptive Immunotherapy
Cell Line
Kidney Neoplasms
Interleukin-2 Receptors
Neuraminidase
Renal Cell Carcinoma
Nude Mice
Growth

ASJC Scopus subject areas

  • Immunology

Cite this

Wang, J., Suthanthiran, M., Walle, A., Lagman, M., Schwartz, R., Murthi, V., ... Stenzel, K. H. (1986). Anti-tumor properties of lymphocytes activated by the oxidizing mitogens. Journal of Immunology, 136(12), 4735-4739.

Anti-tumor properties of lymphocytes activated by the oxidizing mitogens. / Wang, J.; Suthanthiran, Manikkam; Walle, A.; Lagman, M.; Schwartz, R.; Murthi, V.; Novogrodsky, A.; Stenzel, K. H.

In: Journal of Immunology, Vol. 136, No. 12, 27.08.1986, p. 4735-4739.

Research output: Contribution to journalArticle

Wang, J, Suthanthiran, M, Walle, A, Lagman, M, Schwartz, R, Murthi, V, Novogrodsky, A & Stenzel, KH 1986, 'Anti-tumor properties of lymphocytes activated by the oxidizing mitogens', Journal of Immunology, vol. 136, no. 12, pp. 4735-4739.
Wang J, Suthanthiran M, Walle A, Lagman M, Schwartz R, Murthi V et al. Anti-tumor properties of lymphocytes activated by the oxidizing mitogens. Journal of Immunology. 1986 Aug 27;136(12):4735-4739.
Wang, J. ; Suthanthiran, Manikkam ; Walle, A. ; Lagman, M. ; Schwartz, R. ; Murthi, V. ; Novogrodsky, A. ; Stenzel, K. H. / Anti-tumor properties of lymphocytes activated by the oxidizing mitogens. In: Journal of Immunology. 1986 ; Vol. 136, No. 12. pp. 4735-4739.
@article{f22f22c7e85d4c808a579de0227ccc11,
title = "Anti-tumor properties of lymphocytes activated by the oxidizing mitogens",
abstract = "Human peripheral blood mononuclear cells when activated with the oxidizing mitogens, neuraminidase/galactose oxidase or sodium periodate, express cytolytic activity for freshly isolated tumor cells and for a variety of cell lines, including NK-resistant solid tumor lines. Normal lymphoid cells are not targets for cytotoxicity and do not inhibit lysis of susceptible targets mediated by the oxidizing mitogen-activated mononuclear cells. The cytotoxic response is rapidly generated and reaches peak levels at 48 hr. The oxidizing mitogens induce expression of IL 2 receptors on peripheral blood mononuclear cells. Combined treatment of cells with IL 2 and the oxidizing mitogens results in a marked enhancement of cytotoxicity. Enhancement is achieved at levels of IL 2 that alone result in minimal generation of cytotoxic cells. Growth of a human renal cancer cell line in nude mice was inhibited when the renal cancer cells were injected together with oxidizing mitogen-activated human mononuclear cells. These studies indicate that oxidizing mitogen-activated cells provide a potentially valuable source of material for the adoptive immunotherapy of tumors.",
author = "J. Wang and Manikkam Suthanthiran and A. Walle and M. Lagman and R. Schwartz and V. Murthi and A. Novogrodsky and Stenzel, {K. H.}",
year = "1986",
month = "8",
day = "27",
language = "English",
volume = "136",
pages = "4735--4739",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - Anti-tumor properties of lymphocytes activated by the oxidizing mitogens

AU - Wang, J.

AU - Suthanthiran, Manikkam

AU - Walle, A.

AU - Lagman, M.

AU - Schwartz, R.

AU - Murthi, V.

AU - Novogrodsky, A.

AU - Stenzel, K. H.

PY - 1986/8/27

Y1 - 1986/8/27

N2 - Human peripheral blood mononuclear cells when activated with the oxidizing mitogens, neuraminidase/galactose oxidase or sodium periodate, express cytolytic activity for freshly isolated tumor cells and for a variety of cell lines, including NK-resistant solid tumor lines. Normal lymphoid cells are not targets for cytotoxicity and do not inhibit lysis of susceptible targets mediated by the oxidizing mitogen-activated mononuclear cells. The cytotoxic response is rapidly generated and reaches peak levels at 48 hr. The oxidizing mitogens induce expression of IL 2 receptors on peripheral blood mononuclear cells. Combined treatment of cells with IL 2 and the oxidizing mitogens results in a marked enhancement of cytotoxicity. Enhancement is achieved at levels of IL 2 that alone result in minimal generation of cytotoxic cells. Growth of a human renal cancer cell line in nude mice was inhibited when the renal cancer cells were injected together with oxidizing mitogen-activated human mononuclear cells. These studies indicate that oxidizing mitogen-activated cells provide a potentially valuable source of material for the adoptive immunotherapy of tumors.

AB - Human peripheral blood mononuclear cells when activated with the oxidizing mitogens, neuraminidase/galactose oxidase or sodium periodate, express cytolytic activity for freshly isolated tumor cells and for a variety of cell lines, including NK-resistant solid tumor lines. Normal lymphoid cells are not targets for cytotoxicity and do not inhibit lysis of susceptible targets mediated by the oxidizing mitogen-activated mononuclear cells. The cytotoxic response is rapidly generated and reaches peak levels at 48 hr. The oxidizing mitogens induce expression of IL 2 receptors on peripheral blood mononuclear cells. Combined treatment of cells with IL 2 and the oxidizing mitogens results in a marked enhancement of cytotoxicity. Enhancement is achieved at levels of IL 2 that alone result in minimal generation of cytotoxic cells. Growth of a human renal cancer cell line in nude mice was inhibited when the renal cancer cells were injected together with oxidizing mitogen-activated human mononuclear cells. These studies indicate that oxidizing mitogen-activated cells provide a potentially valuable source of material for the adoptive immunotherapy of tumors.

UR - http://www.scopus.com/inward/record.url?scp=0022574210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022574210&partnerID=8YFLogxK

M3 - Article

VL - 136

SP - 4735

EP - 4739

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -